Product Information
AIMOVIG 140 MG/ML AUTOINJECTOR is a brand product labeled by Amgen Inc., priced at $753.3259 per ML under NDC 55513084301. Its NADAC has been published 381 times since Jun 19, 2019.
Strength
140 mg/mL
Manufacturer
Amgen Inc.NDC
55513084301
Classification
Brand
Dosage Form
INJECTION, SOLUTION
Route
SUBCUTANEOUS
Effective Date
9/23/2026
Active Ingredients
ERENUMABApproval Type
Biologic (BLA)
FDA Application
BLA761077On Market Since
3/15/2019
Price Statistics
The NADAC for AIMOVIG 140 MG/ML AUTOINJECTOR has been published 381 times since Jun 19, 2019, and over the history we have for it it has risen 35.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $753.3259 per ML |
|---|---|
| All-time high | $753.9416 (May 13, 2026) |
| All-time low | $554.3750 (Jun 19, 2019) |
| 52-week high | $753.9416 |
| 52-week low | $739.0576 |
| Median price | $711.4652 |
| Average price | $671.8822 |
| Largest weekly change | +5.9% (Feb 2, 2022) |
| Weeks tracked | 381 |
| Tracking since | Jun 19, 2019 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the erenumab-aooe market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Amgen Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
erenumab-aooe market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of AIMOVIG 140 MG/ML AUTOINJECTOR?
The current National Average Drug Acquisition Cost (NADAC) for AIMOVIG 140 MG/ML AUTOINJECTOR, manufactured by Amgen Inc., is $753.3259 per ML (NDC 55513084301), effective Sep 30, 2026.
How has the price of AIMOVIG 140 MG/ML AUTOINJECTOR changed over time?
Over the history we have for it, the NADAC for AIMOVIG 140 MG/ML AUTOINJECTOR has risen 35.9%. It has been tracked across 381 weekly CMS publications since Jun 19, 2019.
What are the highest and lowest recorded NADAC prices for AIMOVIG 140 MG/ML AUTOINJECTOR?
Since Jun 19, 2019, the NADAC for AIMOVIG 140 MG/ML AUTOINJECTOR has ranged from a low of $554.3750 (Jun 19, 2019) to a high of $753.9416 (May 13, 2026), with a median of $711.4652 per ML.
Are there cheaper alternatives to AIMOVIG 140 MG/ML AUTOINJECTOR?
No other NADAC-published product currently shares the active ingredient and strength of AIMOVIG 140 MG/ML AUTOINJECTOR in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures AIMOVIG 140 MG/ML AUTOINJECTOR?
AIMOVIG 140 MG/ML AUTOINJECTOR (NDC 55513084301) is labeled by Amgen Inc., and CMS classifies it as a brand product.